Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing piperazine estrone sulfate (medicinal product) | Is a | Estrogen receptor agonist-containing product | false | Inferred relationship | Some | ||
| Product containing piperazine estrone sulfate (medicinal product) | Is a | Estrogen receptor agonist-containing product | false | Inferred relationship | Some | ||
| Product containing piperazine estrone sulfate (medicinal product) | Has active ingredient | Estrogen | false | Inferred relationship | Some | ||
| Product containing piperazine estrone sulfate (medicinal product) | Has active ingredient | Estropipate | false | Inferred relationship | Some | ||
| Product containing piperazine estrone sulfate (medicinal product) | Is a | Corticosteroid and/or corticosteroid derivative-containing product | false | Inferred relationship | Some | ||
| Product containing piperazine estrone sulfate (medicinal product) | Is a | Product containing estrone (medicinal product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Estropipate 1.5 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Piperazine estrone sulfate adverse reaction | Causative agent | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Piperazine oestrone sulphate allergy | Causative agent | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 1.5 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 1.25 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Product containing precisely estropipate 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 750 microgram oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 3 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 2.5 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 1.5mg tablet (product) | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Piperazine estrone sulfate adverse reaction | Causative agent | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Estropipate 1.5 mg oral tablet | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Product containing estropipate in vaginal dosage form (medicinal product form) | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some | |
| Product containing estropipate in oral dosage form (medicinal product form) | Is a | False | Product containing piperazine estrone sulfate (medicinal product) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set